True North Advisors LLC Takes $644,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

True North Advisors LLC acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 6,857 shares of the company’s stock, valued at approximately $644,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Quent Capital LLC increased its stake in GE HealthCare Technologies by 18.4% during the third quarter. Quent Capital LLC now owns 766 shares of the company’s stock valued at $72,000 after acquiring an additional 119 shares during the period. Wynn Capital LLC raised its stake in shares of GE HealthCare Technologies by 4.1% in the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock valued at $284,000 after acquiring an additional 122 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in GE HealthCare Technologies by 8.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock worth $135,000 after acquiring an additional 127 shares during the last quarter. Quarry LP raised its position in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock valued at $46,000 after purchasing an additional 131 shares during the last quarter. Finally, Tempus Wealth Planning LLC raised its holdings in GE HealthCare Technologies by 0.5% during the 2nd quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock worth $2,407,000 after purchasing an additional 141 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Up 0.7 %

GEHC stock opened at $90.69 on Wednesday. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.55. The stock has a market cap of $41.40 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 3.40 and a beta of 1.18. The company has a fifty day moving average price of $86.57 and a two-hundred day moving average price of $83.27. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period last year, the business posted $0.92 earnings per share. The business’s revenue for the quarter was up .5% compared to the same quarter last year. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is 3.51%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on GEHC. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price on the stock. Finally, Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, five have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.